2015-2027 Global Biologics and Biosimilars Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

2015-2027 Global Biologics and Biosimilars Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 Key Findings of the Study

3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Biologics and Biosimilars Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Biologics and Biosimilars Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 Value Chain of the Biologics and Biosimilars Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 Global Biologics and Biosimilars Market-Segmentation by Type
5.1 Adalimumab (Humira)
5.2 Trastuzumab (Herceptin)
5.3 Hormone
5.4 Others

6 Global Biologics and Biosimilars Market-Segmentation by Application
6.1 Tumor
6.2 Diabetes
6.3 Cardiovascular
6.4 Hemophilia
6.5 Others

7 Global Biologics and Biosimilars Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 Competitive Intelligence - Company Profiles
8.1 Roche
8.1.1 Roche Profile
8.1.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Roche Product/Solution Launches and Enhancements Analysis
8.1.4 Roche Business Overview/Recent Development/Acquisitions
8.2 Pfizer
8.2.1 Pfizer Profile
8.2.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.2.4 Pfizer Business Overview/Recent Development/Acquisitions
8.3 CP Guojian
8.3.1 CP Guojian Profile
8.3.2 CP Guojian Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 CP Guojian Product/Solution Launches and Enhancements Analysis
8.3.4 CP Guojian Business Overview/Recent Development/Acquisitions
8.4 AbbVie
8.4.1 AbbVie Profile
8.4.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 AbbVie Product/Solution Launches and Enhancements Analysis
8.4.4 AbbVie Business Overview/Recent Development/Acquisitions
8.5 3sbio
8.5.1 3sbio Profile
8.5.2 3sbio Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 3sbio Product/Solution Launches and Enhancements Analysis
8.5.4 3sbio Business Overview/Recent Development/Acquisitions
8.6 Amgen
8.6.1 Amgen Profile
8.6.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Amgen Product/Solution Launches and Enhancements Analysis
8.6.4 Amgen Business Overview/Recent Development/Acquisitions
8.7 Dong Bao
8.7.1 Dong Bao Profile
8.7.2 Dong Bao Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Dong Bao Product/Solution Launches and Enhancements Analysis
8.7.4 Dong Bao Business Overview/Recent Development/Acquisitions
8.8 Eli Lilly
8.8.1 Eli Lilly Profile
8.8.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.8.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.9 Changchun High Tech
8.9.1 Changchun High Tech Profile
8.9.2 Changchun High Tech Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Changchun High Tech Product/Solution Launches and Enhancements Analysis
8.9.4 Changchun High Tech Business Overview/Recent Development/Acquisitions
8.10 Novo Nordisk
8.10.1 Novo Nordisk Profile
8.10.2 Novo Nordisk Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Novo Nordisk Product/Solution Launches and Enhancements Analysis
8.10.4 Novo Nordisk Business Overview/Recent Development/Acquisitions
8.11 Johnson & Johnson
8.11.1 Johnson & Johnson Profile
8.11.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.11.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.12 Sanofi-Aventis
8.12.1 Sanofi-Aventis Profile
8.12.2 Sanofi-Aventis Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Sanofi-Aventis Product/Solution Launches and Enhancements Analysis
8.12.4 Sanofi-Aventis Business Overview/Recent Development/Acquisitions
8.13 Ganlee
8.13.1 Ganlee Profile
8.13.2 Ganlee Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Ganlee Product/Solution Launches and Enhancements Analysis
8.13.4 Ganlee Business Overview/Recent Development/Acquisitions
8.14 Innovent
8.14.1 Innovent Profile
8.14.2 Innovent Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Innovent Product/Solution Launches and Enhancements Analysis
8.14.4 Innovent Business Overview/Recent Development/Acquisitions
8.15 Biotech
8.15.1 Biotech Profile
8.15.2 Biotech Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Biotech Product/Solution Launches and Enhancements Analysis
8.15.4 Biotech Business Overview/Recent Development/Acquisitions
8.16 Gelgen
8.16.1 Gelgen Profile
8.16.2 Gelgen Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Gelgen Product/Solution Launches and Enhancements Analysis
8.16.4 Gelgen Business Overview/Recent Development/Acquisitions
8.17 United Laboratories
8.17.1 United Laboratories Profile
8.17.2 United Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 United Laboratories Product/Solution Launches and Enhancements Analysis
8.17.4 United Laboratories Business Overview/Recent Development/Acquisitions
8.18 Merck
8.18.1 Merck Profile
8.18.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Merck Product/Solution Launches and Enhancements Analysis
8.18.4 Merck Business Overview/Recent Development/Acquisitions
8.19 Novartis
8.19.1 Novartis Profile
8.19.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 Novartis Product/Solution Launches and Enhancements Analysis
8.19.4 Novartis Business Overview/Recent Development/Acquisitions

9 Global Biologics and Biosimilars Market-Segmentation by Geography

10 North America
10.1 North America Biologics and Biosimilars Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Biologics and Biosimilars Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Biologics and Biosimilars Production Analysis from 2015-2020
10.4 North America Biologics and Biosimilars Consumption Analysis from 2015-2020
10.5 North America Biologics and Biosimilars Import and Export from 2015-2020
10.6 North America Biologics and Biosimilars Value, Production and Market Share by Type (2015-2020)
10.7 North America Biologics and Biosimilars Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Biologics and Biosimilars by Country (United States, Canada)
10.8.1 North America Biologics and Biosimilars Sales by Country (2015-2020)
10.8.2 North America Biologics and Biosimilars Consumption Value by Country (2015-2020)
10.9 North America Biologics and Biosimilars Market PEST Analysis

11 Europe
11.1 Europe Biologics and Biosimilars Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Biologics and Biosimilars Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Biologics and Biosimilars Production Analysis from 2015-2020
11.4 Europe Biologics and Biosimilars Consumption Analysis from 2015-2020
11.5 Europe Biologics and Biosimilars Import and Export from 2015-2020
11.6 Europe Biologics and Biosimilars Value, Production and Market Share by Type (2015-2020)
11.7 Europe Biologics and Biosimilars Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Biologics and Biosimilars by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Biologics and Biosimilars Sales by Country (2015-2020)
11.8.2 Europe Biologics and Biosimilars Consumption Value by Country (2015-2020)
11.9 Europe Biologics and Biosimilars Market PEST Analysis

12 Asia-Pacific
12.1 Asia-Pacific Biologics and Biosimilars Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Biologics and Biosimilars Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Biologics and Biosimilars Production Analysis from 2015-2020
12.4 Asia-Pacific Biologics and Biosimilars Consumption Analysis from 2015-2020
12.5 Asia-Pacific Biologics and Biosimilars Import and Export from 2015-2020
12.6 Asia-Pacific Biologics and Biosimilars Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Biologics and Biosimilars Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Biologics and Biosimilars by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Biologics and Biosimilars Sales by Country (2015-2020)
12.8.2 Asia-Pacific Biologics and Biosimilars Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Biologics and Biosimilars Market PEST Analysis

13 Latin America
13.1 Latin America Biologics and Biosimilars Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Biologics and Biosimilars Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Biologics and Biosimilars Production Analysis from 2015-2020
13.4 Latin America Biologics and Biosimilars Consumption Analysis from 2015-2020
13.5 Latin America Biologics and Biosimilars Import and Export from 2015-2020
13.6 Latin America Biologics and Biosimilars Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Biologics and Biosimilars Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Biologics and Biosimilars by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Biologics and Biosimilars Sales by Country (2015-2020)
13.8.2 Latin America Biologics and Biosimilars Consumption Value by Country (2015-2020)
13.9 Latin America Biologics and Biosimilars Market PEST Analysis

14 Middle East & Africa
14.1 Middle East & Africa Biologics and Biosimilars Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Biologics and Biosimilars Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Biologics and Biosimilars Production Analysis from 2015-2020
14.4 Middle East & Africa Biologics and Biosimilars Consumption Analysis from 2015-2020
14.5 Middle East & Africa Biologics and Biosimilars Import and Export from 2015-2020
14.6 Middle East & Africa Biologics and Biosimilars Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Biologics and Biosimilars Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Biologics and Biosimilars by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Biologics and Biosimilars Sales by Country (2015-2020)
14.8.2 Middle East & Africa Biologics and Biosimilars Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Biologics and Biosimilars Market PEST Analysis

15 Future Forecast of the Global Biologics and Biosimilars Market from 2020-2027
15.1 Future Forecast of the Global Biologics and Biosimilars Market from 2020-2027 Segment by Region
15.2 Global Biologics and Biosimilars Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Biologics and Biosimilars Consumption and Growth Rate Forecast by Application (2020-2027)

16 Appendix
16.1 Methodology
16.2 Research Data Source

List of Tables and Figures
Global Biologics and Biosimilars Market Value ($) and Growth Rate of Biologics and Biosimilars from 2015-2027
Global Biologics and Biosimilars Production and Growth Rate Segment by Product Type from 2015-2027
Global Biologics and Biosimilars Consumption and Growth Rate Segment by Application from 2015-2027
Figure Biologics and Biosimilars Picture
Table Product Specifications of Biologics and Biosimilars
Table Driving Factors for this Market
Table Industry News of Biologics and Biosimilars Market
Figure Value Chain Status of Biologics and Biosimilars
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Biologics and Biosimilars Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Biologics and Biosimilars Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Adalimumab (Humira) of Biologics and Biosimilars
Figure Trastuzumab (Herceptin) of Biologics and Biosimilars
Figure Hormone of Biologics and Biosimilars
Figure Others of Biologics and Biosimilars
Table Global Biologics and Biosimilars Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Biologics and Biosimilars Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Tumor of Biologics and Biosimilars
Figure Diabetes of Biologics and Biosimilars
Figure Cardiovascular of Biologics and Biosimilars
Figure Hemophilia of Biologics and Biosimilars
Figure Others of Biologics and Biosimilars
Table Global Biologics and Biosimilars Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Biologics and Biosimilars Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Biologics and Biosimilars
Figure Online Channel of Biologics and Biosimilars
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table CP Guojian Profile (Company Name, Plants Distribution, Sales Region)
Figure CP Guojian Sales and Growth Rate from 2015-2020
Figure CP Guojian Revenue ($) and Global Market Share from 2015-2020
Table CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table AbbVie Profile (Company Name, Plants Distribution, Sales Region)
Figure AbbVie Sales and Growth Rate from 2015-2020
Figure AbbVie Revenue ($) and Global Market Share from 2015-2020
Table AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table 3sbio Profile (Company Name, Plants Distribution, Sales Region)
Figure 3sbio Sales and Growth Rate from 2015-2020
Figure 3sbio Revenue ($) and Global Market Share from 2015-2020
Table 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Amgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Amgen Sales and Growth Rate from 2015-2020
Figure Amgen Revenue ($) and Global Market Share from 2015-2020
Table Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dong Bao Profile (Company Name, Plants Distribution, Sales Region)
Figure Dong Bao Sales and Growth Rate from 2015-2020
Figure Dong Bao Revenue ($) and Global Market Share from 2015-2020
Table Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Changchun High Tech Profile (Company Name, Plants Distribution, Sales Region)
Figure Changchun High Tech Sales and Growth Rate from 2015-2020
Figure Changchun High Tech Revenue ($) and Global Market Share from 2015-2020
Table Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novo Nordisk Profile (Company Name, Plants Distribution, Sales Region)
Figure Novo Nordisk Sales and Growth Rate from 2015-2020
Figure Novo Nordisk Revenue ($) and Global Market Share from 2015-2020
Table Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi-Aventis Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi-Aventis Sales and Growth Rate from 2015-2020
Figure Sanofi-Aventis Revenue ($) and Global Market Share from 2015-2020
Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ganlee Profile (Company Name, Plants Distribution, Sales Region)
Figure Ganlee Sales and Growth Rate from 2015-2020
Figure Ganlee Revenue ($) and Global Market Share from 2015-2020
Table Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Innovent Profile (Company Name, Plants Distribution, Sales Region)
Figure Innovent Sales and Growth Rate from 2015-2020
Figure Innovent Revenue ($) and Global Market Share from 2015-2020
Table Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biotech Profile (Company Name, Plants Distribution, Sales Region)
Figure Biotech Sales and Growth Rate from 2015-2020
Figure Biotech Revenue ($) and Global Market Share from 2015-2020
Table Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Gelgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Gelgen Sales and Growth Rate from 2015-2020
Figure Gelgen Revenue ($) and Global Market Share from 2015-2020
Table Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table United Laboratories Profile (Company Name, Plants Distribution, Sales Region)
Figure United Laboratories Sales and Growth Rate from 2015-2020
Figure United Laboratories Revenue ($) and Global Market Share from 2015-2020
Table United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Biologics and Biosimilars Production Value ($) by Region from 2015-2020
Table Global Biologics and Biosimilars Production Value Share by Region from 2015-2020
Table Global Biologics and Biosimilars Production by Region from 2015-2020
Table Global Biologics and Biosimilars Consumption Value ($) by Region from 2015-2020
Table Global Biologics and Biosimilars Consumption by Region from 2015-2020
Table North America Biologics and Biosimilars Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Biologics and Biosimilars Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Biologics and Biosimilars Import and Export from 2015-2020
Table North America Biologics and Biosimilars Value ($) by Type (2015-2020)
Table North America Biologics and Biosimilars Production by Type (2015-2020)
Table North America Biologics and Biosimilars Consumption by Application (2015-2020)
Table North America Biologics and Biosimilars Consumption by Country (2015-2020)
Table North America Biologics and Biosimilars Consumption Value ($) by Country (2015-2020)
Figure North America Biologics and Biosimilars Market PEST Analysis
Table Europe Biologics and Biosimilars Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Biologics and Biosimilars Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Biologics and Biosimilars Import and Export from 2015-2020
Table Europe Biologics and Biosimilars Value ($) by Type (2015-2020)
Table Europe Biologics and Biosimilars Production by Type (2015-2020)
Table Europe Biologics and Biosimilars Consumption by Application (2015-2020)
Table Europe Biologics and Biosimilars Consumption by Country (2015-2020)
Table Europe Biologics and Biosimilars Consumption Value ($) by Country (2015-2020)
Figure Europe Biologics and Biosimilars Market PEST Analysis
Table Asia-Pacific Biologics and Biosimilars Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Biologics and Biosimilars Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Biologics and Biosimilars Import and Export from 2015-2020
Table Asia-Pacific Biologics and Biosimilars Value ($) by Type (2015-2020)
Table Asia-Pacific Biologics and Biosimilars Production by Type (2015-2020)
Table Asia-Pacific Biologics and Biosimilars Consumption by Application (2015-2020)
Table Asia-Pacific Biologics and Biosimilars Consumption by Country (2015-2020)
Table Asia-Pacific Biologics and Biosimilars Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market PEST Analysis
Table Latin America Biologics and Biosimilars Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Biologics and Biosimilars Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Biologics and Biosimilars Import and Export from 2015-2020
Table Latin America Biologics and Biosimilars Value ($) by Type (2015-2020)
Table Latin America Biologics and Biosimilars Production by Type (2015-2020)
Table Latin America Biologics and Biosimilars Consumption by Application (2015-2020)
Table Latin America Biologics and Biosimilars Consumption by Country (2015-2020)
Table Latin America Biologics and Biosimilars Consumption Value ($) by Country (2015-2020)
Figure Latin America Biologics and Biosimilars Market PEST Analysis
Table Middle East & Africa Biologics and Biosimilars Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Biologics and Biosimilars Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Biologics and Biosimilars Import and Export from 2015-2020
Table Middle East & Africa Biologics and Biosimilars Value ($) by Type (2015-2020)
Table Middle East & Africa Biologics and Biosimilars Production by Type (2015-2020)
Table Middle East & Africa Biologics and Biosimilars Consumption by Application (2015-2020)
Table Middle East & Africa Biologics and Biosimilars Consumption by Country (2015-2020)
Table Middle East & Africa Biologics and Biosimilars Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Biologics and Biosimilars Market PEST Analysis
Table Global Biologics and Biosimilars Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Biologics and Biosimilars Production and Growth Rate Forecast by Region (2020-2027)
Table Global Biologics and Biosimilars Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Biologics and Biosimilars Production and Growth Rate Forecast by Type (2020-2027)
Table Global Biologics and Biosimilars Consumption and Growth Rate Forecast by Application (2020-2027)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs